THE SHRUBBERY SURGERY — All Prescriptions & Medications — Page 9
Practice Code: G82021 | GRAVESEND, DA11 8RD
Showing results 401-450 of 690
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| Brinzolamide/brimonidine | 60 | 600 | £1.1K | +74.9% ▲ |
| Emollient bath and shower preparations | 60 | 25.0K | £421 | -4.5% ▼ |
| Terbinafine hydrochloride | 60 | 2,220 | £401 | +61.7% ▲ |
| 60 | 1,510 | £618 | +52.2% ▲ | |
| 60 | 446 | £1.2K | +147.7% ▲ | |
| Dabigatran etexilate | 59 | 2,976 | £2.5K | +14.0% ▲ |
| Liquid OTC glucose for diabetic hypo treatment (0913541) | 58 | 46.6K | £706 | +153.1% ▲ |
| Brivaracetam | 57 | 4,228 | £9.8K | +67.6% ▲ |
| 57 | 2,040 | £3.3K | +274.2% ▲ | |
| Alfuzosin hydrochloride | 56 | 2,934 | £898 | -21.7% ▼ |
| 56 | 510 | £183 | -73.2% ▼ | |
| Insulin degludec | 55 | 279 | £3.0K | -50.0% ▼ |
| Metformin hydrochloride/sitagliptin | 55 | 5,488 | £1.4K | +46.9% ▲ |
| Tibolone | 55 | 4,256 | £788 | +79.7% ▲ |
| 55 | 1,439 | £993 | +48.5% ▲ | |
| Erythromycin | 54 | 2,882 | £1.0K | +55.9% ▲ |
| Pioglitazone hydrochloride | 54 | 3,248 | £175 | -38.9% ▼ |
| Clobazam | 53 | 11.5K | £2.1K | -19.6% ▼ |
| Levonorgestrel | 53 | 54 | £4.3K | +40.4% ▲ |
| Calcium acetate | 53 | 1,701 | £184 | +186.4% ▲ |
| Olopatadine | 53 | 355 | £355 | +20.8% ▲ |
| Sodium picosulfate | 52 | 9,800 | £894 | +43.3% ▲ |
| Oxcarbazepine | 52 | 2,184 | £355 | +86.0% ▲ |
| 52 | 495 | £145 | +79.5% ▲ | |
| Prednisolone | 51 | 1,110 | £121 | -29.1% ▼ |
| Duloxetine hydrochloride | 51 | 2,065 | £354 | -0.5% vs avg |
| Hydroxycarbamide | 51 | 2,974 | £692 | +76.8% ▲ |
| Terbutaline sulphate | 50 | 74 | £437 | -7.8% ▼ |
| Zolpidem tartrate | 50 | 824 | £39 | -44.5% ▼ |
| Clomipramine hydrochloride | 50 | 1,960 | £288 | +18.6% ▲ |
| Diphtheria | 50 | 50 | £363 | -25.1% ▼ |
| 50 | 590 | £389 | +16.0% ▲ | |
| Piroxicam | 49 | 4,916 | £127 | -14.7% ▼ |
| Tacrolimus | 49 | 1,590 | £1.3K | -9.1% ▼ |
| Chlorhexidine gluconate | 49 | 35.3K | £671 | +65.9% ▲ |
| 49 | 108 | £696 | +37.1% ▲ | |
| 48 | 6,319 | £831 | -2.9% ▼ | |
| Co-beneldopa (Benserazide/levodopa) | 47 | 6,400 | £489 | -68.9% ▼ |
| Glucagon | 47 | 62 | £900 | +209.0% ▲ |
| Solifenacin/tamsulosin | 47 | 1,710 | £1.5K | +128.7% ▲ |
| Exemestane | 47 | 2,738 | £515 | +44.6% ▲ |
| Estradiol valerate | 46 | 4,928 | £408 | +135.5% ▲ |
| 46 | 6,401 | £234 | -46.0% ▼ | |
| Lofepramine hydrochloride | 45 | 1,832 | £1.1K | +50.4% ▲ |
| Oestrogens conjugated | 45 | 3,472 | £1.2K | +120.5% ▲ |
| Ibandronic acid | 45 | 91 | £99 | +23.8% ▲ |
| Aceclofenac | 45 | 3,720 | £511 | +365.5% ▲ |
| 45 | 1,015 | £1.8K | +62.6% ▲ | |
| 45 | 50 | £374 | +625.7% ▲ | |
| 45 | 1,760 | £3.6K | +119.5% ▲ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.